Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials.
2016
AIM
To evaluate the current role of sorafenib, an oral multikinase inhibitor in the treatment of breast cancer.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
22
Citations
NaN
KQI